People In Brief
This article was originally published in The Gray Sheet
Executive Summary
MDMA chair: Delcath Systems' CEO Eamonn Hobbs took over the Medical Device Manufacturers Association board of directors as chairman May 25 during the group's annual meeting in Washington, D.C. He replaces outgoing chair Joe Kiani, CEO of Masimo. Hobbs joined Delcath, which develops novel delivery systems for cancer drugs, last July. He co-founded interventional radiology and oncology firm AngioDynamics in 1988 and served as its president and CEO until early 2009 (1"The Gray Sheet" July 20, 2009)
You may also be interested in...
People In Brief
The latest moves by movers and shakers in the medical device and diagnostics industries
People In Brief
Interventional pulmonology CEO: Emphysema device developer Pulmonx announced the hiring of Michael A. Baker as president and CEO July 15. Baker resigned from his 11-year post as CEO of ArthroCare in February in the shadow of an accounting scandal and government investigations (1"The Gray Sheet" Feb. 23, 2009). He also previously served as an executive for Medtronic. The Pulmonx announcement comes two months after the start-up acquired failed endobronchial valve-maker Emphasys Medical and several weeks following 510(k) clearance of its Chartis collateral ventilation detection system, which can be used to identify candidates best suited for lung volume reduction procedures using the Emphasys EBV valve (2"The Gray Sheet" May 18, 2009). Former CEO Ronald Steckel left the firm in November 2008
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.